drugset / Trial / NCT01352507
A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China
RandomizedCrossoverOpen-labelTreatment
Summary
The primary objective of this study is to evaluate whether, after two 8-week treatment periods, male patients with erectile dysfunction (ED) in China prefer 20 milligram (mg) tadalafil or 100 mg sildenafil. This trial consists of two treatment periods of 8 weeks each and an extension phase of 8 weeks, for a total of 24 weeks.
Timeline
- Start
- 2011-06
- Primary completion
- 2012-06
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | 100 mg | Oral |
| Subject | Tadalafil | Small molecule | 20 mg | Oral |